1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Foveal RGCs develop abnormal calcium dynamics weeks after photoreceptor ablation

      Preprint
      research-article
      1 , , Ph.D. 2 , 1 , , O.D., Ph.D. 4 , 5 , , Ph.D. 2 , 3
      bioRxiv
      Cold Spring Harbor Laboratory

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective or purpose

          Physiological changes in retinal ganglion cells (RGCs) have been reported in rodent models of photoreceptor (PR) loss but this has not been investigated in primates. By expressing both a calcium indicator (GCaMP6s) and an optogenetic actuator (ChrimsonR) in foveal RGCs of the macaque, we reactivated RGCs in vivo and assessed their response in the weeks and years following PR loss.

          Design

          We used an in vivo calcium imaging approach to record optogenetically evoked activity in deafferented RGCs in primate fovea. Cellular scale recordings were made longitudinally over a 10 week period following photoreceptor ablation and compared to RGC responses from RGCs that had lost photoreceptor input more than two years prior.

          Participants

          Three eyes received photoreceptor ablation, OD of a male Macacus mulatta (M1), OS of a female Macacus fascicularis (M2) and OD of a male Macacus fascicularis (M3). Two animals were used for in vivo recording, one for histological assessment.

          Methods

          Cones were ablated with an ultrafast laser delivered through an adaptive optics scanning light ophthalmoscope (AOSLO). A 0.5 s pulse of 25Hz 660nm light was delivered to optogenetically stimulate the deafferented RGCs, and the resulting GCaMP fluorescence signal was recorded from RGCs with an AOSLO. These measurements were repeated over the 10 weeks immediately after photoreceptor ablation and at 2 years.

          Main Outcome measures

          The rise time, decay constant and response magnitude of the deafferented RGCs responding to optogenetic stimulation was derived from GCaMP fluorescence recordings from 221 RGCs (Animal M1) and 218 RGCs (Animal M2) in vivo.

          Results

          The mean time to the peak calcium response was stable in deafferented RGCs over the 10-week post ablation observation period, while the mean decay constant of the calcium response decreased by 1.5 fold 1.6±0.5 s to 0.6±0.3 s within 10 weeks in subject 1 and 2.1 fold (2.5±0.5 s to 1.2±0.2 s SD) within 8 weeks in subject 2.

          Conclusions

          We observe abnormal calcium dynamics developing in primate foveal RGCs in the weeks after photoreceptor ablation. The mean decay constant of the optogenetic mediated calcium response decreased 1.5 – 2-fold. This is the first report of this phenomenon in primate retina and further work is required to understand the role these changes play in cell survival and activity. Nevertheless, the presence of optogenetic mediated responses 2 years after PR loss and the stable rise time remain promising for vision restoration therapies.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          Independent Optical Excitation of Distinct Neural Populations

          Optogenetic tools enable the causal examination of how specific cell types contribute to brain circuit functions. A long-standing question is whether it is possible to independently activate two distinct neural populations in mammalian brain tissue. Such a capability would enable the examination of how different synapses or pathways interact to support computation. Here we report two new channelrhodopsins, Chronos and Chrimson, obtained through the de novo sequencing and physiological characterization of opsins from over 100 species of algae. Chrimson is 45 nm red-shifted relative to any previous channelrhodopsin, important for scenarios where red light would be preferred; we show minimal visual system mediated behavioral artifact in optogenetically stimulated Drosophila. Chronos has faster kinetics than any previous channelrhodopsin, yet is effectively more light-sensitive. Together, these two reagents enable crosstalk-free two-color activation of neural spiking and downstream synaptic transmission in independent neural populations in mouse brain slice.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators

            Genetically encoded calcium indicators (GECIs) can be used to image activity in defined neuronal populations. However, current GECIs produce inferior signals compared to synthetic indicators and recording electrodes, precluding detection of low firing rates. We developed a single-wavelength GECI based on GCaMP2 (GCaMP3), with increased baseline fluorescence (3x), dynamic range (3x), and higher affinity for calcium (1.3x). GCaMP3 fluorescence changes triggered by single action potentials were detected in pyramidal cell dendrites, with signal-to-noise ratio and photostability significantly better than GCaMP2, D3cpVenus, and TN-XXL. In Caenorhabditis elegans chemosensory neurons and the Drosophila melanogaster antennal lobe, sensory stimulation-evoked fluorescence responses were significantly enhanced with the new indicator (4–6x). In somatosensory and motor cortical neurons in the intact mouse, GCaMP3 detected calcium transients with amplitudes linearly dependent on action potential number. Long-term imaging in the motor cortex of behaving mice revealed large fluorescence changes in imaged neurons over months.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Partial recovery of visual function in a blind patient after optogenetic therapy

              Optogenetics may enable mutation-independent, circuit-specific restoration of neuronal function in neurological diseases. Retinitis pigmentosa is a neurodegenerative eye disease where loss of photoreceptors can lead to complete blindness. In a blind patient, we combined intraocular injection of an adeno-associated viral vector encoding ChrimsonR with light stimulation via engineered goggles. The goggles detect local changes in light intensity and project corresponding light pulses onto the retina in real time to activate optogenetically transduced retinal ganglion cells. The patient perceived, located, counted and touched different objects using the vector-treated eye alone while wearing the goggles. During visual perception, multichannel electroencephalographic recordings revealed object-related activity above the visual cortex. The patient could not visually detect any objects before injection with or without the goggles or after injection without the goggles. This is the first reported case of partial functional recovery in a neurodegenerative disease after optogenetic therapy.
                Bookmark

                Author and article information

                Journal
                bioRxiv
                BIORXIV
                bioRxiv
                Cold Spring Harbor Laboratory
                30 June 2023
                : 2023.05.30.542908
                Affiliations
                [1 ]Institute of Optics, University of Rochester, Rochester, New York, UNITED STATES
                [2 ]Center for Visual Science, University of Rochester Medical Center, Rochester, New York, UNITED STATES
                [3 ]Department of Ophthalmology, University of Rochester Medical Center, Rochester, New York, UNITED STATES
                [4 ]Herbert Wertheim School of Optometry & Vision Science, University of California Berkeley, Berkeley, California, UNITED STATES
                [5 ]Helen Wills Neuroscience Institute, University of California Berkeley, Berkeley, California, UNITED STATES
                Article
                10.1101/2023.05.30.542908
                10312553
                37398439
                7c9f82af-1c11-452c-9e62-8d24f6e4c6e0

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.

                History
                Funding
                Funded by: National Institutes of Health
                Award ID: U24 EY033275
                Award ID: NIH EY024265
                Funded by: University of Rochester
                Award ID: NIH EY001319
                Funded by: UC Berkeley
                Award ID: NIH EY003176
                Funded by: Flaum Eye Institute
                Funded by: CRL Molecular Imaging Center at UC Berkeley
                Award ID: RRID:SCR_017852
                Funded by: Helen Wills Neuroscience Institute
                Categories
                Article

                Comments

                Comment on this article